MYRIAD

Myriad Genetics, Inc

Application Filed: 2023-09-22
Trademark Application Details
Trademark Logo MYRIAD
630
Live/Pending
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Research OneLook Acronym Finder
Serial Number98193395
Mark Drawing Code4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Attorney NameKatherine P. Califa
Attorney Docket Number131588-

Timeline

2019-01-15Date of First Use
2023-09-22Application Filed
2023-09-26Location: NEW APPLICATION PROCESSING
2023-09-26Status: Live/Pending
2023-09-26Transaction Date

Trademark Applicants & Owners

Owner: Myriad Genetics, Inc
Address320 Wakara Way Salt Lake City DE 84108
Legal Entity TypeCorporation
Legal Entity StateDE

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

KATHERINE P. CALIFA
FOLEY & LARDNER LLP
3000 K STREET, N.W.
SIXTH FLOOR
WASHINGTON, DC 20007

Good, Services, and Codes

International Codes:5
U.S. Codes:005,006,018,044,046,051,052
International Codes:10
U.S. Codes:026,039,044
International Codes:42
U.S. Codes:100,101
International Codes:44
U.S. Codes:100,101
Type CodeType
GS0051Medical test kits comprising chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; medical diagnostic reagents, assays, chemical preparations, and diagnostic test kits consisting primarily of reagents for medical diagnostic purposes, namely, testing of fluids; chemical reagents for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic test kits comprised of chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic kits consisting primarily of reagents for body fluid analysis and nucleic acid analysis and for detecting genetic conditions, disorders, and diseases for medical use

Trademark Filing History

DescriptionDateEvent Coding
NEW APPLICATION ENTERED2023-09-261 NWAP I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED2023-10-102 NWOS I:Incoming Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed